These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28443355)

  • 41. Improving Current Treatments for Schizophrenia.
    Maric NP; Jovicic MJ; Mihaljevic M; Miljevic C
    Drug Dev Res; 2016 Nov; 77(7):357-367. PubMed ID: 27633376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies.
    Price R; Salavati B; Graff-Guerrero A; Blumberger DM; Mulsant BH; Daskalakis ZJ; Rajji TK
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():83-91. PubMed ID: 24819820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blockade of dopamine D₃ but not D₂ receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment.
    Watson DJ; Marsden CA; Millan MJ; Fone KC
    Int J Neuropsychopharmacol; 2012 May; 15(4):471-84. PubMed ID: 21414250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationale for Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia.
    Kinon BJ; Leucht S; Tamminga C; Breier A; Marcus R; Paul SM
    J Clin Psychiatry; 2024 Aug; 85(3):. PubMed ID: 39196873
    [No Abstract]   [Full Text] [Related]  

  • 45. Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
    Leucht S
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S15-20. PubMed ID: 14972080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perospirone. SM 9018.
    Drugs R D; 1999 Jul; 2(1):60-2. PubMed ID: 10610286
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.
    Miyamoto S; Duncan GE; Marx CE; Lieberman JA
    Mol Psychiatry; 2005 Jan; 10(1):79-104. PubMed ID: 15289815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of new antipsychotic medications: occupancy is not just antagonism.
    Grunder G; Carlsson A; Wong DF
    Arch Gen Psychiatry; 2003 Oct; 60(10):974-7. PubMed ID: 14557141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of dopamine D(2) receptors for antipsychotic activity.
    Ginovart N; Kapur S
    Handb Exp Pharmacol; 2012; (212):27-52. PubMed ID: 23129327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lumateperone: New Drug or Same Old Drug With a New Dress?
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2020 Jun; 58(6):9-12. PubMed ID: 32463907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schizophrenia: an illness of distorted reality.
    Dean B
    Biologist (London); 2000 Sep; 47(4):202-6. PubMed ID: 11153121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
    Suzuki H; Gen K; Inoue Y
    J Psychopharmacol; 2013 Apr; 27(4):396-400. PubMed ID: 23427194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure.
    Gonsai NH; Amin VH; Mendpara CG; Speth R; Hale GM
    J Clin Pharm Ther; 2018 Feb; 43(1):1-7. PubMed ID: 29119585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE data.
    Moriguchi S; Bies RR; Remington G; Suzuki T; Mamo DC; Watanabe K; Mimura M; Pollock BG; Uchida H
    J Clin Psychopharmacol; 2013 Oct; 33(5):682-5. PubMed ID: 23899638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment.
    Tsai SJ
    Med Hypotheses; 2004; 63(6):1047-50. PubMed ID: 15504573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
    Depoortère R; Bardin L; Auclair AL; Kleven MS; Prinssen E; Colpaert F; Vacher B; Newman-Tancredi A
    Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.